- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Apr 30, 2026 | 14.21M sh |
| Shares Diluted | Q3 2026 · Mar 29, 2026 | 14.3M sh |
| Shares Diluted | Q3 2026 · Mar 29, 2026 | 14.3M sh |
| Shares Diluted | Q3 2026 · Mar 30, 2025 | 14.53M sh |
| Shares Diluted | Q3 2026 · Mar 30, 2025 | 14.62M sh |
| Stock Repurchased | Q3 2026 · Mar 29, 2026 | $0 |
| Stock Repurchased | Q3 2026 · Mar 30, 2025 | $1.21M |
| Capex | Q3 2026 · Mar 29, 2026 | $49K |
| Capex | Q3 2026 · Mar 30, 2025 | $44K |
| Operating Cash Flow | Q3 2026 · Mar 29, 2026 | $2.05M |
| Operating Cash Flow restated | Q3 2026 · Mar 30, 2025 | $2.2M |
| Short Term Investments | Q3 2026 · Mar 29, 2026 | $10.86M |
| Short Term Investments | Q3 2026 · Jun 29, 2025 | $7.02M |
| Cash And Equivalents | Q3 2026 · Mar 29, 2026 | $1.15M |
| Cash And Equivalents | Q3 2026 · Jun 29, 2025 | $2.86M |
| Stockholders Equity | Q3 2026 · Mar 29, 2026 | $16.45M |
| Stockholders Equity | Q3 2026 · Dec 28, 2025 | $15.54M |
| Stockholders Equity | Q3 2026 · Sep 28, 2025 | $14.84M |
| Stockholders Equity | Q3 2026 · Jun 29, 2025 | $14.15M |
| Stockholders Equity | Q3 2026 · Mar 30, 2025 | $13.35M |
| Stockholders Equity | Q3 2026 · Dec 29, 2024 | $13.78M |
| Stockholders Equity | Q3 2026 · Sep 29, 2024 | $13.3M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $12.7M |
| Current Liabilities | Q3 2026 · Mar 29, 2026 | $1.66M |
| Current Liabilities | Q3 2026 · Jun 29, 2025 | $1.74M |
| Total Liabilities | Q3 2026 · Mar 29, 2026 | $2.13M |
| Total Liabilities | Q3 2026 · Jun 29, 2025 | $2.4M |
| Current Assets | Q3 2026 · Mar 29, 2026 | $14.36M |
| Current Assets | Q3 2026 · Jun 29, 2025 | $11.49M |
| Total Assets | Q3 2026 · Mar 29, 2026 | $18.58M |
| Total Assets | Q3 2026 · Jun 29, 2025 | $16.56M |
| Eps Diluted | Q3 2026 · Mar 29, 2026 | $0.06 |
| Eps Diluted | Q3 2026 · Mar 29, 2026 | $0.15 |
| Eps Diluted | Q3 2026 · Mar 30, 2025 | $0.05 |
| Eps Diluted | Q3 2026 · Mar 30, 2025 | $0.13 |
| Eps Basic | Q3 2026 · Mar 29, 2026 | $0.06 |
| Eps Basic | Q3 2026 · Mar 29, 2026 | $0.15 |
| Eps Basic | Q3 2026 · Mar 30, 2025 | $0.05 |
| Eps Basic | Q3 2026 · Mar 30, 2025 | $0.13 |
| Sga Expense | Q3 2026 · Mar 29, 2026 | $1.47M |
| Sga Expense | Q3 2026 · Mar 29, 2026 | $4.37M |
| Sga Expense restated | Q3 2026 · Mar 30, 2025 | $1.31M |
| Sga Expense restated | Q3 2026 · Mar 30, 2025 | $4.05M |
| Net Income | Q3 2026 · Mar 29, 2026 | $800K |
| Net Income | Q3 2026 · Mar 29, 2026 | $2.08M |
| Net Income | Q3 2026 · Dec 28, 2025 | $637K |
| Net Income | Q3 2026 · Sep 28, 2025 | $645K |
| Net Income | Q3 2026 · Mar 30, 2025 | $722K |
| Net Income | Q3 2026 · Mar 30, 2025 | $1.86M |
| Net Income | Q3 2026 · Dec 29, 2024 | $607K |
| Net Income | Q3 2026 · Sep 29, 2024 | $526K |
| Operating Income | Q3 2026 · Mar 29, 2026 | $957K |
| Operating Income | Q3 2026 · Mar 29, 2026 | $2.45M |
| Operating Income | Q3 2026 · Mar 30, 2025 | $855K |
| Operating Income | Q3 2026 · Mar 30, 2025 | $2.13M |
| Revenue | Q3 2026 · Mar 29, 2026 | $3.22M |
| Revenue | Q3 2026 · Mar 29, 2026 | $9.48M |
| Revenue | Q3 2026 · Mar 30, 2025 | $2.97M |
| Revenue | Q3 2026 · Mar 30, 2025 | $8.89M |